BVF I GP LLC's Net Worth
$159 Million
Who is BVF I GP LLC?
BVF I GP LLC has an estimated net worth of $159 Million. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Oncology Inc., XOMA Corp, Cullinan Oncology, Inc., Merus N.V., Repare Therapeutics Inc., Verastem, Inc., CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, Principia Biopharma Inc., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., PIERIS PHARMACEUTICALS, INC., Third Harmonic Bio, Inc., FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., enGene Holdings Inc., POINT Biopharma Global Inc., GLYCOMIMETICS INC, and INFINITY PHARMACEUTICALS, INC..
SEC CIK
BVF I GP LLC's CIK is 0001803805
Past Insider Trading and Trends
2020 was BVF I GP LLC's most active year for acquiring shares with 116 total transactions. BVF I GP LLC's most active month to acquire stocks was the month of April. 2020 was BVF I GP LLC's most active year for disposing of shares, totalling 33 transactions. BVF I GP LLC's most active month to dispose stocks was the month of May. 2021 saw BVF I GP LLC paying a total of $132,144,944.64 for 12,405,370 shares, this is the most they've acquired in one year. In 2020 BVF I GP LLC cashed out on 15,626,103.772 shares for a total of $157,004,308.58, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allakos Inc. (ALLK) Snapshot price: $1.2625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rain Oncology Inc. (RAIN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.58M |
—
|
—
|
0
|
Jan 25 - Jan 26
| |||
Form 4
| +47.80% | 1.71M |
$5.83 | $9,971,387.14 | 5.29M |
Nov 8
| |||
Form 4
| +20.43% | 557.73K |
$12.00 | $6,692,637.85 | 3.29M |
Jan 6 - Jan 7
| |||
Form 4
| +0.41% | 11.03K |
$13.94 | $153,828.71 | 2.73M |
Sep 21
| |||
Form 4
| +16.86% | 392.27K |
$16.49 | $6,468,515.81 | 2.72M |
Sep 13
| |||
Form 4
| +33.73% | 587K |
$15.47 | $9,078,692.10 | 2.33M |
Jul 1 - Jul 6
| |||
Form 4
| +7.63% | 123.35K |
$15.94 | $1,966,334.17 | 1.74M |
May 21 - May 24
| |||
Form 4
| +14.80% | 208.47K |
$16.59 | $3,457,720.14 | 1.62M |
May 18 - May 19
| |||
Form 4
| +4.30% | 58K |
$14.26 | $827,167.00 | 1.41M |
May 13
| |||
Form 4/A
| +522.18% | 1.13M |
$16.86 | $19,103,379.78 | 1.35M |
Apr 23 - Apr 26
| |||
Form 4
|
∞
| 4.93M |
$16.86 |
—
| 4.93M |
Apr 23 - Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cullinan Oncology, Inc. (CGEM) Snapshot price: $18.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -86.30% | -6.40M |
—
|
—
| 1.02M |
Jan 19
| |||
Form 4
| +11.27% | 751.4K |
$11.00 | $8,264,905.16 | 7.42M |
Jun 1
| |||
Form 4
| +19.98% | 1.11M |
$9.09 | $10,063,936.50 | 6.66M |
May 12 - May 13
| |||
Form 4
| +5.55% | 276K |
$10.75 | $2,966,972.40 | 5.25M |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Repare Therapeutics Inc. (RPTX) Snapshot price: $7.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.52% | 1.23M |
$5.19 | $6,249,889.20 | 20.04M |
Nov 15 - Nov 16
| |||
Form 4
| +9.61% | 783.71K |
$3.60 | $2,821,352.40 | 8.94M |
Nov 2
| |||
Form 4
| +1.86% | 149.16K |
$12.73 | $1,898,819.53 | 8.16M |
Jun 13
| |||
Form 4
| +29.77% | 1.84M |
$11.90 | $21,859,328.55 | 8.01M |
Jun 2 - Jun 6
| |||
Form 4
| +7.30% | 420K |
$8.50 | $3,570,000.00 | 6.17M |
May 18
| |||
Form 4
| +21.00% | 1M |
$14.10 | $14,071,250.10 | 5.75M |
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Verastem, Inc. (VSTM) Snapshot price: $13.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |